CERo Therapeutics announces the activation of the University of California, Davis as a clinical trial site for the ongoing Phase 1 CERTAIN-T trial of CER-1236 in hematologic malignancies.
🇺🇸 USA · קליפורניה · Map
CERo Therapeutics announces the activation of the University of California, Davis as a clinical trial site for the ongoing Phase 1 CERTAIN-T trial of CER-1236 in hematologic malignancies.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in